Pharyngitis News and Research

RSS
Takeda underscores commitment to ACTOS following FDA and EMA announcements for rosiglitazone

Takeda underscores commitment to ACTOS following FDA and EMA announcements for rosiglitazone

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Education, changes in reimbursement practices can reduce inappropriate antibiotic usage: Study

Education, changes in reimbursement practices can reduce inappropriate antibiotic usage: Study

Study suggests reimbursements can address inappropriate antibiotic usage

Study suggests reimbursements can address inappropriate antibiotic usage

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis

Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

Student-led team awarded top honor in 2010 CIMIT Prize in Primary Healthcare competition

Student-led team awarded top honor in 2010 CIMIT Prize in Primary Healthcare competition

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Japan's MHLW grants full marketing authorization to REVLIMID

Japan's MHLW grants full marketing authorization to REVLIMID

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS

Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS

Clinical data from investigational study of patients with multiple myeloma presented at ASCO

Clinical data from investigational study of patients with multiple myeloma presented at ASCO

Researchers present data from Phase II study of lenalidomide in patients with untreated CLL at ASCO

Researchers present data from Phase II study of lenalidomide in patients with untreated CLL at ASCO

Pernix Therapeutics Holdings acquires oral third-generation cephalosporin, CEDAX

Pernix Therapeutics Holdings acquires oral third-generation cephalosporin, CEDAX

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

New analysis suggests physicians should change their diagnosis and treatment for sore throat

New analysis suggests physicians should change their diagnosis and treatment for sore throat